If an online deal is too good to be true, it's probably a scam.

Emerging Voices features regular contributions from scholars and practitioners highlighting new research, thinking, and approaches to development challenges. This article is from Paul Callan, Jasmin …

In an interview today on CFR.org, CFR Senior Fellow Thomas Bollyky discusses the environmental and development issues on the table at the Rio+20 Conference. Bollyky suggests that the conference’s ult…

In a CFR.org interview last week timed to the one-year anniversary of a UN high-level meeting on the subject, CFR senior fellow Thomas Bollyky discussed global progress on combating noncommunicable d…

As the Chinese government looks to restart the country's economy, business leaders remain uncertain about the future of economic policy. 

In light of an Indian court’s refusal to grant a patent to the leukemia drug Gleevec, CFR senior fellow Thomas Bollyky wrote yesterday about the tension between pharmaceutical firms seeking compensat…

In an article yesterday on CNN, CFR senior fellow Thomas Bollyky surveyed the tension between two leading global health concerns: protecting pharmaceutical firms’ intellectual property (IP) and impro…

Last week, CFR senior fellow Thomas Bollyky published an Expert Brief analyzing the impact of the new Global Burden of Disease (GBD) Study, which measures levels of disease and other health phenomena…

Emerging Voices features regular contributions from scholars and practitioners highlighting new research, thinking, and approaches to development challenges. This article is from Paul Callan, Jasmin …

The World Next Week podcast is up. Bob McMahon and I discussed the upcoming U.S.-India strategic dialogue; the U.S. House breaking for its Flag Day recess; and the International Criminal Court’s (ICC…